U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C15H23NO2.ClH
Molecular Weight 285.81
Optical Activity ( + / - )
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of O-DESMETHYL TRAMADOL HYDROCHLORIDE

SMILES

Cl.CN(C)C[C@H]1CCCC[C@]1(O)C2=CC(O)=CC=C2

InChI

InChIKey=IRGWVAWLHXDKIX-PBCQUBLHSA-N
InChI=1S/C15H23NO2.ClH/c1-16(2)11-13-6-3-4-9-15(13,18)12-7-5-8-14(17)10-12;/h5,7-8,10,13,17-18H,3-4,6,9,11H2,1-2H3;1H/t13-,15+;/m1./s1

HIDE SMILES / InChI

Molecular Formula C15H23NO2
Molecular Weight 249.3486
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

O-Desmethyl tramadol (O-Desmethyltramadol, O-DSMT) is a metabolite of tramadol. O-Desmethyltramadol is an opioid analgesic and the main active metabolite of tramadol. (+)-O-Desmethyltramadol is the most important metabolite of tramadol produced in the liver after tramadol is consumed. This metabolite is considerably more potent as a μ-opioid agonist than the parent compound. O-desmethyl tramadol, inhibits 5-hydroxytryptamine type 2C receptors expressed in xenopus oocytes. O-desmethyl tramadol inhibits functions of M(1) receptors but has little effect on those of M(3) receptors. O-desmethyl tramadol has been widely used clinically and has analgesic activity.

Approval Year

PubMed

PubMed

TitleDatePubMed
Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effects of main active metabolites of tramadol, (+)-O-desmethyltramadol and (-)-O-desmethyltramadol, in rats.
2000 May
Modeling of the in vivo antinociceptive interaction between an opioid agonist, (+)-O-desmethyltramadol, and a monoamine reuptake inhibitor, (-)-O-desmethyltramadol, in rats.
2000 Oct
Inhibition of CYP2D6-mediated tramadol O-demethylation in methadone but not buprenorphine maintenance patients.
2012 Nov
Effects of tramadol and o-desmethyltramadol on canine innate immune system function.
2015 May
Patents

Sample Use Guides

In Vivo Use Guide
Curator's Comment: The administration of 10 mg/kg (+)-O-desmethyl tramadol in a 10-min i.v. infusion significantly altered pCO(2), pO(2), and pH values in comparison with baseline and lower-dose groups. However, 2 mg/kg administered in a 10-min i.v. infusion was enough to achieve 100% antinociception without respiratory depression in rats. https://www.ncbi.nlm.nih.gov/pubmed/10773040
Oral Light: 15 – 30 mg Common: 30 – 50 mg Strong: 50 – 70+ mg
Route of Administration: Oral
O-desmethyl tramadol (0.1-100 uM) inhibited acetylcholine (ACh)-induced currents in oocytes expressing the M(1) receptors (half-maximal inhibitory concentration [IC(50)] = 2 +/- 0.6 uM), whereas it did not suppress ACh-induced currents in oocytes expressing the M(3) receptor. O-desmethyl tramadol inhibited the specific binding of [(3)H]quinuclidinyl benzilate ([(3)H]QNB) to the oocytes expressed M(1) receptors (IC(50) = 10.1 +/- 0.1 uM), whereas it did not suppress the specific binding of [(3)H]QNB to the oocytes expressed M(3) receptors.
Substance Class Chemical
Created
by admin
on Sat Dec 16 08:20:19 UTC 2023
Edited
by admin
on Sat Dec 16 08:20:19 UTC 2023
Record UNII
XL5VDC061E
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
O-DESMETHYL TRAMADOL HYDROCHLORIDE
Common Name English
PHENOL, 3-(2-((DIMETHYLAMINO)METHYL)-1-HYDROXYCYCLOHEXYL)-, HYDROCHLORIDE, CIS-
Common Name English
PHENOL, 3-((1R,2R)-2-((DIMETHYLAMINO)METHYL)-1-HYDROXYCYCLOHEXYL)-, HYDROCHLORIDE, REL-
Systematic Name English
PHENOL, 3-((1R,2R)-2-((DIMETHYLAMINO)METHYL)-1-HYDROXYCYCLOHEXYL)-, HYDROCHLORIDE (1:1), REL-
Systematic Name English
O-DEMETHYLTRAMADOL HYDROCHLORIDE
Common Name English
Code System Code Type Description
EPA CompTox
DTXSID10617163
Created by admin on Sat Dec 16 08:20:19 UTC 2023 , Edited by admin on Sat Dec 16 08:20:19 UTC 2023
PRIMARY
PUBCHEM
9838802
Created by admin on Sat Dec 16 08:20:19 UTC 2023 , Edited by admin on Sat Dec 16 08:20:19 UTC 2023
PRIMARY
FDA UNII
XL5VDC061E
Created by admin on Sat Dec 16 08:20:19 UTC 2023 , Edited by admin on Sat Dec 16 08:20:19 UTC 2023
PRIMARY
CAS
16412-54-7
Created by admin on Sat Dec 16 08:20:19 UTC 2023 , Edited by admin on Sat Dec 16 08:20:19 UTC 2023
NON-SPECIFIC STEREOCHEMISTRY
CAS
185453-02-5
Created by admin on Sat Dec 16 08:20:19 UTC 2023 , Edited by admin on Sat Dec 16 08:20:19 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY